Performance of high-dose omalizumab in chronic urticaria is predicted by initial improvement to standard dose

Affiliations

• ¹ Urticaria Centre of Excellence and Reference (UCARE), Department of Dermatology/Allergology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: [email protected].
• ² Urticaria Centre of Excellence and Reference (UCARE), Department of Dermatology/Allergology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
• ³ Department of Dermatology, Radboud University Medical Centre, Nijmegen, the Netherlands.